Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DIST_0826_sciadv.aaz9890

An FGF21, GLP-1 fusion protein for diabetes, obesity

Sep 30, 2020 | 8:20 PM GMT

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE